Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 6, 2007, Pages 1672-1677

  Shetty, Anil M ^a   Stafford, R Jason ^a   Elliott, Andrew M ^a   Kassouf, Wassim ^a   Brown, Gordon A ^a   Stephens, L Clifton ^a   Tinkey, Peggy T ^a   Bidaut, Luc ^a   Pisters, Louis L ^a   Hazle, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Animal model; Convective therapy; Imaging guided therapy; Magnetic resonance imaging; Prostate

Indexed keywords

GADOLINIUM PENTETATE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOG; DRUG DISTRIBUTION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; RATING SCALE; STATISTICAL SIGNIFICANCE; THERMODYNAMICS;

ANIMALS; CONTRAST MEDIA; DOGS; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; GADOLINIUM DTPA; INJECTIONS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; METHYLENE BLUE; PROSTATE;

EID: 37349102706     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21206     Document Type: Article

References (21)

1. Ries LAG, Harkins D, Krapcho M, et al. SEER cancer statistics review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
2. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358-1367.
3. Hazle JD, Diederich CJ, Kangasniemi M, Price RE, Olsson LE, Stafford RJ. MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator. J Magn Reson Imaging 2002;15:409-417.
4. Wientjes MG, Zheng JH, Hu L, Gan Y, Au JL. Intraprostatic chemotherapy: distribution and transport mechanisms. Clin Cancer Res 2005;11:4204-4211.
5. Salomir R, Palussiere J, Fossheim SL, et al. Local delivery of magnetic resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR imaging-guided local hyperthermia: a feasibility study in vivo. J Magn Reson Imaging 2005;22:534-540.
6. Pennock GD, Dalton WS, Roeske WR, et al. Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. J Natl Cancer Inst 1991;83:105-110.
7. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994;271:58-65.
8. Shi F, Rakhmilevich AL, Heise CP, et al. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther 2002;1:949-957.
9. Sangro B, Mazzolini G, Ruiz J, et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol 2004;22:1389-1397.
10. Pardridge WM. Drug delivery to the brain. J Cereb Blood Flow Metab 1997;17:713-731.
11. Firusian N, Dempke W. An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. Cancer 1999;85:980-987.
12. Jackson JK, Gleave ME, Yago V, Beraldi E, Hunter WL, Burt HM. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Cancer Res 2000;60:4146-4151.
13. Steiner MS, Gingrich JR. Gene therapy for prostate cancer: where are we now? J Urol 2000;164:1121-1136.
14. Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 2005;62:140-147.
15. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002;94:2511-2516.
16. Hata N, Jinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology 2001;220:263-268.
17. O'Hara AJ, Howell JM, Taplin RH, et al. The spread of transgene expression at the site of gene construct injection. Muscle Nerve 2001;24:488-495.
18. Rosser CJ, Stafford RJ, Price RE, et al. Ex-vivo intraprostatic injection of contrast to delineate distribution of solution injected into the prostate. Gene Ther Mol Biol 2004;8:1-5.
19. Bland JM, Altaian DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;11:307-310.
20. Wang Y, Wang H, Li CY, Yuan F. Effects of rate, volume, and dose of intratumoral infusion on virus dissemination in local gene delivery. Mol Cancer Ther 2006;5:362-366.
21. Madersbacher S, Grobl M, Kramer G, Dirnhofer S, Steiner GE, Marberger M. Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate 1998;37:174-181.